Halloran to Present at Industry Events in May

Mon, May 8th 2017

NewYorkBIO, CMO East and Clinical Leader Forum to offer Halloran’s Expertise

BOSTON, May 8, 2017 – Halloran Consulting Group, a national consultancy to life science companies of all sizes, will provide industry expertise at leading life science gatherings in May, including, NewYorkBIOConvergence ForumChief Medical Office East Summit and the Clinical Leader Forum.

“We are thrilled to participate in each of these impactful events, as they foster innovation and forward thinking in life sciences,” said Laurie Halloran. “Coming together to brainstorm and collaborate on tough issues is imperative to the success of our industry, and we are pleased to be a part of these important conversations.”

As a life science leader with headquarters in Boston, Halloran supports and leads several groundbreaking industry initiatives.

  • Chief Medical Office East Summit – Halloran Principal Consultant Iva Toudjarska, PhD, will speak on “Indication Assessment as a Powerful Tool in the Development Arsenal” at 9:45 a.m. ET on Wednesday, May 10. COO, Greg Dombal, and Director of Business Development, Lori Kaiser, also will attend CMO East to connect with leaders in biotech. CMO East is an annual gathering for physicians to exchange best practices in the advancement of drug development within the confines of the emerging biotech space.
  • Clinical Leader Forum – Halloran President and CEO Laurie Halloran will discuss strategies on “How Top-Performing Pharma Companies Audit Their CRO.” Laurie Halloran’s speaking engagement will take place on May 10 at 10:15 a.m. ET. Principal Consultant, Keri Urwin, will also be attending the event. The Clinical Leader Forum brings together leaders in life science to discuss the barriers to a fast and efficient clinical trial to create actionable solutions for the future.
  • NewYorkBIO2017 Annual Conference – Laurie Halloran, will also speak on alternative business models for early life science development at on Thursday, May 11 at 10:00 a.m. ET. Laurie will be speaking alongside Michael Foley, Sanders Director of Tri-Institutional Therapeutics Discovery Institute & The Sanders Innovation and Education Initiative, Lara Sullivan, VP of Pfizer CURES, Pfizer Medical, David Donovan of Roswell Park Cancer Institute and Rajesh Ranganathan, Director of Translational Medicine Initiatives & Clinical Department of Medicine, Massachusetts General Hospital. Halloran Consultant, Andrew Barrett, will also be in attendance. NewYorkBIO’s 2017 Annual Conference brings together emerging and established companies, investors, business development professionals, scientists and others supporting and advancing life science discoveries.
  • Convergence Forum – Laurie Halloran, Greg Dombal, Lori Kaiser and Managing Director, Katie McCarthy, will join the annual ideas exchange, Convergence Forum to hear industry insight and vision from life science leaders across New England.

About Halloran Consulting Group
Halloran Consulting Group is a management consulting firm that partners with life science companies to optimize their development. Halloran works with industry organizations of all types, including biotech, pharma, medical device, and service providers, to identify gaps and implement solutions to achieve excellence in regulatory, quality, and clinical development. Halloran is certified by the Women’s Business Enterprise National Council as a woman-owned business. For more information, please visit www.hallorancg.com. Follow us on Twitter: @HalloranConsult.

Press Contact
Kelsey Williams
Matter – 971.361.9606